The global CRISPR gene editing market size is calculated at USD 4.77 billion in 2025 and is expected to reach around USD ...

Citrus greening is a disease with no known cure that has infected nearly every citrus grove. It first cropped up 20 years ago. There's still no cure.

Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the disease ...

Calidi Biotherapeutics Inc. has spent over 10 years developing a groundbreaking platform for the systemic delivery of genetic medicines that can precisely target tumors. One of the company's core ...

Bacteria and their phage, “are full of mysteries and also lots of really powerful mechanisms that we can study and potentially harness.” ...

NetworkNewsWire Editorial Coverage NEW YORK, July 9, 2025 /PRNewswire/ -- Each year, approximately 20 million people are diagnosed with cancer, and nearly 10 million lives are lost to the ...

According to Texas Lt Governor Dan Patrick, the Guadalupe River rose 26 feet in a span of just 45 minutes, unleashing a ...

A high-level overview of CRISPR Therapeutics AG (CRSP) stock. View (CRSP) real-time stock price, chart, news, analysis, analyst reviews and more.

Declaring independence from both Democrats and Republicans, Musk said his new 'America Party' will return power to the people ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

Your guide to the most essential developments in life sciences.

Stay up-to-date on CRISPR Therapeutics AG Common Shares (CRSP) news with the latest updates, breaking headlines, news articles, and more from around the web at Nasdaq.com.